177 related articles for article (PubMed ID: 35757853)
1. Lessons learned from the preclinical discovery and development of sarilumab for the treatment of rheumatoid arthritis.
Maioli G; Caporali R; Favalli EG
Expert Opin Drug Discov; 2022 Aug; 17(8):799-813. PubMed ID: 35757853
[TBL] [Abstract][Full Text] [Related]
2. Profile of sarilumab and its potential in the treatment of rheumatoid arthritis.
Raimondo MG; Biggioggero M; Crotti C; Becciolini A; Favalli EG
Drug Des Devel Ther; 2017; 11():1593-1603. PubMed ID: 28579757
[TBL] [Abstract][Full Text] [Related]
3. Room for more IL-6 blockade? Sarilumab for the treatment of rheumatoid arthritis.
June RR; Olsen NJ
Expert Opin Biol Ther; 2016 Oct; 16(10):1303-9. PubMed ID: 27464017
[TBL] [Abstract][Full Text] [Related]
4. Indirect Treatment Comparison of the Efficacy and Safety of Sarilumab Monotherapy in Rheumatoid Arthritis Patients with Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs.
Choy E; Freemantle N; Proudfoot C; Chen CI; Pollissard L; Kuznik A; van Hoogstraten H; Mangan E; Carita P; Huynh TM
Adv Ther; 2019 Apr; 36(4):817-827. PubMed ID: 30864105
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of sarilumab in combination with csDMARDs or as monotherapy in subpopulations of patients with moderately to severely active rheumatoid arthritis in three phase III randomized, controlled studies.
Genovese MC; Fleischmann R; Kivitz A; Lee EB; van Hoogstraten H; Kimura T; St John G; Mangan EK; Burmester GR
Arthritis Res Ther; 2020 Jun; 22(1):139. PubMed ID: 32522251
[TBL] [Abstract][Full Text] [Related]
6. Sarilumab: Review of a Second IL-6 Receptor Antagonist Indicated for the Treatment of Rheumatoid Arthritis.
Boyce EG; Rogan EL; Vyas D; Prasad N; Mai Y
Ann Pharmacother; 2018 Aug; 52(8):780-791. PubMed ID: 29482351
[TBL] [Abstract][Full Text] [Related]
7. Sarilumab monotherapy or in combination with non-methotrexate disease-modifying antirheumatic drugs in active rheumatoid arthritis: A Japan phase 3 trial (HARUKA).
Kameda H; Wada K; Takahashi Y; Hagino O; van Hoogstraten H; Graham N; Tanaka Y
Mod Rheumatol; 2020 Mar; 30(2):239-248. PubMed ID: 31268376
[No Abstract] [Full Text] [Related]
8. Role of Interleukin 6 Inhibitors in the Management of Rheumatoid Arthritis.
Yip RML; Yim CW
J Clin Rheumatol; 2021 Dec; 27(8):e516-e524. PubMed ID: 31876844
[TBL] [Abstract][Full Text] [Related]
9. Sarilumab, a fully human monoclonal antibody against IL-6Rα in patients with rheumatoid arthritis and an inadequate response to methotrexate: efficacy and safety results from the randomised SARIL-RA-MOBILITY Part A trial.
Huizinga TW; Fleischmann RM; Jasson M; Radin AR; van Adelsberg J; Fiore S; Huang X; Yancopoulos GD; Stahl N; Genovese MC
Ann Rheum Dis; 2014 Sep; 73(9):1626-34. PubMed ID: 24297381
[TBL] [Abstract][Full Text] [Related]
10. Economic Evaluation of Sarilumab in the Treatment of Adult Patients with Moderately-to-Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic Disease-Modifying Antirheumatic Drugs.
Muszbek N; Proudfoot C; Fournier M; Chen CI; Kuznik A; Kiss Z; Gal P; Michaud K
Adv Ther; 2019 Jun; 36(6):1337-1357. PubMed ID: 31004324
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the efficacy and safety of tocilizumab, sarilumab, and sirukumab in comparison with adalimumab as monotherapy in patients with active rheumatoid arthritis: A Bayesian network meta-analysis of randomized controlled trials.
Sung YK; Lee YH
Int J Clin Pharmacol Ther; 2021 Sep; 59(9):618-626. PubMed ID: 34281633
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the efficacy and tolerability of tocilizumab, sarilumab, and sirukumab in patients with active rheumatoid arthritis: a Bayesian network meta-analysis of randomized controlled trials.
Bae SC; Lee YH
Clin Rheumatol; 2018 Jun; 37(6):1471-1479. PubMed ID: 29404725
[TBL] [Abstract][Full Text] [Related]
13. Patient-reported outcomes from a randomized phase III trial of sarilumab monotherapy versus adalimumab monotherapy in patients with rheumatoid arthritis.
Strand V; Gossec L; Proudfoot CWJ; Chen CI; Reaney M; Guillonneau S; Kimura T; van Adelsberg J; Lin Y; Mangan EK; van Hoogstraten H; Burmester GR
Arthritis Res Ther; 2018 Jun; 20(1):129. PubMed ID: 29921318
[TBL] [Abstract][Full Text] [Related]
14. A review of sarilumab for the treatment of rheumatoid arthritis.
Lee EB
Immunotherapy; 2018 Jan; 10(1):57-65. PubMed ID: 29043871
[TBL] [Abstract][Full Text] [Related]
15. Effects of Sarilumab on Rheumatoid Arthritis as Reported by Patients Using the Rheumatoid Arthritis Impact of Disease Scale.
Gossec L; Strand V; Proudfoot C; Chen CI; Guillonneau S; Kimura T; van Hoogstraten H; Mangan E; Reaney M
J Rheumatol; 2019 Oct; 46(10):1259-1267. PubMed ID: 30877216
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-6 receptor blockade or TNFα inhibition for reducing glycaemia in patients with RA and diabetes: post hoc analyses of three randomised, controlled trials.
Genovese MC; Burmester GR; Hagino O; Thangavelu K; Iglesias-Rodriguez M; John GS; González-Gay MA; Mandrup-Poulsen T; Fleischmann R
Arthritis Res Ther; 2020 Sep; 22(1):206. PubMed ID: 32907617
[TBL] [Abstract][Full Text] [Related]
17. Sarilumab plus methotrexate in patients with active rheumatoid arthritis and inadequate response to methotrexate: results of a randomized, placebo-controlled phase III trial in Japan.
Tanaka Y; Wada K; Takahashi Y; Hagino O; van Hoogstraten H; Graham NMH; Kameda H
Arthritis Res Ther; 2019 Mar; 21(1):79. PubMed ID: 30894208
[TBL] [Abstract][Full Text] [Related]
18. Long-term safety of sarilumab in rheumatoid arthritis: an integrated analysis with up to 7 years' follow-up.
Fleischmann R; Genovese MC; Lin Y; St John G; van der Heijde D; Wang S; Gomez-Reino JJ; Maldonado-Cocco JA; Stanislav M; Kivitz AJ; Burmester GR
Rheumatology (Oxford); 2020 Feb; 59(2):292-302. PubMed ID: 31312844
[TBL] [Abstract][Full Text] [Related]
19. Long-term safety and efficacy of sarilumab with or without background csDMARDs in rheumatoid arthritis.
Burmester GR; Strand V; Kivitz AJ; Hu CC; Wang S; van Hoogstraten H; Klier GL; Fleischmann R
Rheumatology (Oxford); 2023 Oct; 62(10):3268-3279. PubMed ID: 36727470
[TBL] [Abstract][Full Text] [Related]
20. IL-6 inhibitors for treatment of rheumatoid arthritis: past, present, and future.
Kim GW; Lee NR; Pi RH; Lim YS; Lee YM; Lee JM; Jeong HS; Chung SH
Arch Pharm Res; 2015; 38(5):575-84. PubMed ID: 25648633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
